Robert Hofmeister Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert Hofmeister.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert Hofmeister. Robert Hofmeister is Chief Science Officer in TCR2 THERAPEUTICS INC. ($TCRR) and Chief Scientific Officer in TCR2 THERAPEUTICS INC. ($TCRR).
Latest Insider Trading Transactions of Robert Hofmeister
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 23 2020 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Scientific Of ... | Option Exercise | M | 0.74 | 7,000 | 5,180 | 28,732 | |
Dec 23 2020 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Scientific Of ... | Buy | M | 0.74 | 7,000 | 5,180 | 45,850 | 38.9 K to 45.9 K (+18.02 %) |
Dec 11 2020 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Scientific Of ... | Option Exercise | A | 31.83 | 76,000 | 2,419,080 | 76,000 | |
Nov 13 2020 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Scientific Of ... | Option Exercise | M | 0.74 | 10,002 | 7,401 | 25,730 | |
Nov 13 2020 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Scientific Of ... | Option Exercise | M | 0.74 | 9,998 | 7,399 | 12,348 | |
Nov 13 2020 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Scientific Of ... | Sell | S | 25.10 | 10,002 | 251,050 | 38,850 | 48.9 K to 38.9 K (-20.47 %) |
Nov 13 2020 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Scientific Of ... | Buy | M | 0.74 | 10,002 | 7,401 | 48,852 | 38.9 K to 48.9 K (+25.75 %) |
Nov 13 2020 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Scientific Of ... | Sell | S | 25.10 | 9,998 | 250,950 | 38,850 | 48.8 K to 38.9 K (-20.47 %) |
Nov 13 2020 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Scientific Of ... | Buy | M | 0.74 | 9,998 | 7,399 | 48,848 | 38.9 K to 48.8 K (+25.73 %) |
Nov 02 2020 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Science Offic ... | Option Exercise | M | 0.74 | 20,000 | 14,800 | 22,346 | |
Nov 02 2020 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Science Offic ... | Sell | S | 19.10 | 20,000 | 382,000 | 38,850 | 58.9 K to 38.9 K (-33.98 %) |
Nov 02 2020 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Science Offic ... | Buy | M | 0.74 | 20,000 | 14,800 | 58,850 | 38.9 K to 58.9 K (+51.48 %) |
Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Scientific Of ... | Option Exercise | A | 16.10 | 50,000 | 805,000 | 50,000 | |
Apr 12 2019 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Scientific Of ... | Option Exercise | A | 16.11 | 127,512 | 2,054,218 | 127,512 |
Page: 1